1

Certara

#4064

Rank

$2.28B

Marketcap

US United States

Country

Certara
Leadership team

Dr. William F. Feehery Ph.D. (CEO & Director)

Mr. M. Andrew Schemick (Chief Financial Officer)

Mr. Leif E. Pedersen (Pres of Software)

Products/ Services
Biotechnology, Health Care, Pharmaceutical, Software
Number of Employees
1,000 - 20,000
Headquarters
Princeton, New Jersey, United States
Established
2008
Company Registration
SEC CIK number: 0001827090
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
CERT
Social Media
Overview
Location
Summary
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
History

Certara is first mentioned in 1264 as Certara with the church of S. Pietro Martire.Certara was probably originally a simple alpine herding camp for the village of Sonvico. Although the village remained dependent, until 1899, on the parish of St. Pietro in Colla, it already had its own property in 1591, a cemetery in the 17th century, the Baptistery of S. Rocco in 1670 and also a pastor.The income of the village came mainly from agriculture and cattle breeding but was supplemented by the money sent back to the village by emigrants. Starting in the late 19th century, the village population declined as a result of the decline of agriculture and the formation of the Lugano agglomeration. Today, many houses are used as second or vacation homes.

Mission
Certara unlocks the power of modeling & simulation to bring clarity, rigor and efficiency to drug discovery & development.
Vision
Unlock the power of science to create safe, effective and accessible drugs and therapies, and to bring them to market faster.
Key Team

Dr. Robert P. Aspbury Ph.D. (Pres of Simcyp Division)

Mr. Andrew Schemick (Chief Financial Officer)

Prof. Amin Rostami PharmD, Ph.D., FCP (Chief Scientific Officer)

Mr. Richard M. Traynor (Sr. VP, Gen. Counsel & Sec.)

Ms. Nicolette D. Sherman (Chief HR Officer)

Mr. Ron DiSantis (Sr. VP of Corp. Devel.)

Mr. Jaap Mandema (Chief Innovation Officer)

Recognition and Awards
Certara regulary recieves awards and recognitions for its contribution to the advances in drug and biologic skills. Most recently, Certara recieved several industry awards, including the Frost & Sullivan 2017 and 2018 Global Clinical Pharmacology Modeling & Simulation Enabling Technologies Leadership Award, the PharmaVOICE 100 2019 list, and the Scrip Awards 2018 Modeling & Simulation Service Provider of the Year Award
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Certara
Leadership team

Dr. William F. Feehery Ph.D. (CEO & Director)

Mr. M. Andrew Schemick (Chief Financial Officer)

Mr. Leif E. Pedersen (Pres of Software)

Products/ Services
Biotechnology, Health Care, Pharmaceutical, Software
Number of Employees
1,000 - 20,000
Headquarters
Princeton, New Jersey, United States
Established
2008
Company Registration
SEC CIK number: 0001827090
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
CERT
Social Media